242 related articles for article (PubMed ID: 12787731)
1. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives.
Bisacchi D; Benelli R; Vanzetto C; Ferrari N; Tosetti F; Albini A
Cancer Detect Prev; 2003; 27(3):229-38. PubMed ID: 12787731
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.
Sogno I; Vannini N; Lorusso G; Cammarota R; Noonan DM; Generoso L; Sporn MB; Albini A
Recent Results Cancer Res; 2009; 181():209-12. PubMed ID: 19213570
[TBL] [Abstract][Full Text] [Related]
3. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis and cancer prevention: a vision.
Noonan DM; Benelli R; Albini A
Recent Results Cancer Res; 2007; 174():219-24. PubMed ID: 17302199
[TBL] [Abstract][Full Text] [Related]
5. The Mediterranean Diet, a Rich Source of Angiopreventive Compounds in Cancer.
Martínez-Poveda B; Torres-Vargas JA; Ocaña MDC; García-Caballero M; Medina MÁ; Quesada AR
Nutrients; 2019 Aug; 11(9):. PubMed ID: 31480406
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic properties of chemopreventive drugs: fenretinide as a prototype.
Sogno I; Venè R; Sapienza C; Ferrari N; Tosetti F; Albini A
Recent Results Cancer Res; 2009; 181():71-6. PubMed ID: 19213559
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy.
Sato Y
Int J Clin Oncol; 2003 Aug; 8(4):200-6. PubMed ID: 12955574
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.
Dell'Eva R; Pfeffer U; Indraccolo S; Albini A; Noonan D
Endothelium; 2002; 9(1):3-10. PubMed ID: 12901356
[TBL] [Abstract][Full Text] [Related]
9. Tumor inflammatory angiogenesis and its chemoprevention.
Albini A; Tosetti F; Benelli R; Noonan DM
Cancer Res; 2005 Dec; 65(23):10637-41. PubMed ID: 16322203
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways for cancer angioprevention.
Albini A; Noonan DM; Ferrari N
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4320-5. PubMed ID: 17671111
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent.
Lorusso G; Vannini N; Sogno I; Generoso L; Garbisa S; Noonan DM; Albini A
Eur J Cancer; 2009 May; 45(8):1474-84. PubMed ID: 19223175
[TBL] [Abstract][Full Text] [Related]
12. Mechanism and its regulation of tumor-induced angiogenesis.
Gupta MK; Qin RY
World J Gastroenterol; 2003 Jun; 9(6):1144-55. PubMed ID: 12800214
[TBL] [Abstract][Full Text] [Related]
13. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
14. Growing tumor vessels: more than one way to skin a cat - implications for angiogenesis targeted cancer therapies.
Leite de Oliveira R; Hamm A; Mazzone M
Mol Aspects Med; 2011 Apr; 32(2):71-87. PubMed ID: 21540050
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic application of anti-angiogenic nanomaterials in cancers.
Mukherjee S; Patra CR
Nanoscale; 2016 Jul; 8(25):12444-70. PubMed ID: 27067119
[TBL] [Abstract][Full Text] [Related]
16. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer.
Shanmugam MK; Warrier S; Kumar AP; Sethi G; Arfuso F
Curr Vasc Pharmacol; 2017; 15(6):503-519. PubMed ID: 28707601
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic agents and cancer: current insights and future perspectives.
De Paepe B
Recent Pat Anticancer Drug Discov; 2009 Jun; 4(2):180-5. PubMed ID: 19519541
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic and anti-tumor properties of proteasome inhibitors.
Daniel KG; Kuhn DJ; Kazi A; Dou QP
Curr Cancer Drug Targets; 2005 Nov; 5(7):529-41. PubMed ID: 16305349
[TBL] [Abstract][Full Text] [Related]
19. Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
Tosetti F; Ferrari N; De Flora S; Albini A
FASEB J; 2002 Jan; 16(1):2-14. PubMed ID: 11772931
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.
Lingen MW
Crit Rev Oral Biol Med; 1999; 10(2):153-64. PubMed ID: 10759419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]